A large proportion of the medicines used by humans are extracted directly or indirectly from plant secondary metabolites. These complex compounds, which include groups such as alkaloids, flavonoids, terpenes, and phenolic compounds, have demonstrated significant therapeutic properties, including anticancer, antibacterial, anti-inflammatory, and potent antioxidant effects. However, the increasing pressures of environmental stressors, climate change, and overexploitation of natural resources have placed many plant speciesespecially valuable medicinal plantsat risk of extinction. Under these critical conditions, traditional and direct extraction of these compounds from nature has become an unsustainable and unreliable approach. In such a scenario, plant biotechnology knowledge-particularly tissue culture techniques-has emerged as a promising solution. Methods such as suspension culture of plant cells, callus culture, production of hairy roots using Agrobacterium rhizogenes, genetic metabolic engineering of plants, and the use of advanced bioreactor systems enable the large-scale, controlled, and sustainable production of secondary metabolites in laboratory settings. In addition, these approaches provide precise control over the quality and purity of the final product and help prevent potential contaminants that may occur during traditional extraction processes. Overall, the development and application of these biotechnological strategies not only contribute significantly to the conservation of biodiversity, but also ensure a sustainable and cost-effective supply of materials to meet pharmaceutical and industrial needs for future societies. They offer a clear pathway toward the responsible use of plant resources.